cipamfylline has been researched along with pentoxifylline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badger, AM; Esser, KM; Olivera, DL | 1 |
Bartus, JO; Bugelski, PJ; Esser, KM; Herzyk, DJ; Kaplan, JM; Ruggieri, EV | 1 |
2 other study(ies) available for cipamfylline and pentoxifylline
Article | Year |
---|---|
Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha; Xanthines | 1994 |
Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C.
Topics: Animals; Bronchoalveolar Lavage Fluid; Candida albicans; Cell Survival; Cytotoxicity, Immunologic; Lung; Macrophages; Male; Neutrophil Activation; Neutrophils; Pentoxifylline; Phosphodiesterase Inhibitors; Poly I-C; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Xanthines | 1995 |